Materialise Medical 3D Printing Facility to Deliver Personalized Care

Materialise plans to accelerates delivery of patient-specific medical implants to patients in the United States with the opening of a new 3D printing facility in Plymouth, MI. At the new facility, Materialise specializes in the 3D printing of personalized titanium cranio-maxillofacial (CMF) implants. CMF implants are used for facial reconstructive surgery.

Until now, Materialise manufactured titanium CMF implants solely at its 3D printing facility in Belgium. With a dedicated metal 3D printing facility in the U.S., the company can respond to surgeons’ needs with more reliability while reducing delivery time of personalized implants to hospitals across the United States, the company reports. This expansion of capabilities complements Materialise’s existing production of 3D-printed surgical guides and anatomical models in the United States.

“With the opening of our new metal 3D printing center in the US, we bring personalized care closer to US patients,” says Brigitte de Vet, vice president Medical at Materialise. “The power of 3D printing, paired with our three decades of experience in 3D planning and medical manufacturing, allows us to accelerate the delivery of personalized medical implants. We take pride in leading the charge to revolutionize patient-specific care, and with our dedicated facility in Michigan, we further enhance personalized care in the United States."

Materialise has more than three decades of experience in developing medical solutions and offers a comprehensive range of 3D-printed guides and implants. The company produces 280,000 personalized 3D-printed instruments and implants per year, including 160,000 for the US market. Materialise has pioneered numerous medical 3D printing applications. In 2017, it introduced one of the first personalized CMF implant portfolios in the United States. In 2021, its 3D planning and 3D printed instruments played a role in a simultaneous double hand and face transplant that was successfully performed at NYU Langone Health in Manhattan, New York, the company reports.

Sources: Press materials received from the company and additional information gleaned from the company’s website.